Skip to main content
Premium Trial:

Request an Annual Quote

Image-Pro Plus Version 6.0, Ingenuity Pathways Analysis 3.1, Benchware LibraryMaker 6.0, Benchware LibraryDesigner 2.4, Cellenger MVA, BioModels Database, Cate Sabatini, Don Listwin

Premium

Downloads & Upgrades

Media Cybernetics has released Image-Pro Plus Version 6.0. The latest version of the company's scientific image processing and analysis software includes support for Windows XP x64 operating systems as well as new analysis features, such as color management tools, the ability to classify more than 100,000 objects per image frame, and tools to export data via DDE to programs like Origin and Microsoft Excel.


Ingenuity Systems has launched Ingenuity Pathways Analysis 3.1, a web-based software application for analyzing biological mechanisms, pathways, and functions. The new release integrates with third-party and customer applications through dedicated APIs and supports Affymetrix's GeneChip Human Mapping 10K, 100K, and 500K arrays. The content in IPA 3.1 has also been updated, and currently contains 1.4 million biological findings. Trials are available at http://www.ingenuity.com/trial.


Tripos has released Benchware LibraryMaker 6.0 and Benchware LibraryDesigner 2.4. Product enhancements include increased flexibility for handling compound-protecting groups and improved integration of third-party chemical sketchers, Tripos said. Benchware LibraryMaker's library-enumeration functionality is also being integrated into the company's Benchware Notebook electronic laboratory notebook.


Definiens has released Cellenger MVA, a multivariate image analysis software package for cell-based assays. Cellenger is a set of workflow tools and modular image analysis components. Cellenger MVA is expected to reduced attritions rate and liability risk, and identify more lead compounds with higher quality, the company said.


Release 4 of the BioModels Database is available from the European Bioinformatics Institute at http://www.ebi.ac.uk/biomodels/. The release includes six new models that represent 220 reactions, the biggest increase since the creation of the resource, according to EBI. The release also includes the qualification of annotations, following the recommendation of the MIRIAM standard.

People in the News

Iconix Pharmaceuticals has named Cate Sabatini as executive vice president of business development. Sabatini has held previous positions at Incyte, where she was the director of product development and vice president of customer relations Prior to Incyte, Sabatini was the manager of information systems at LSI Logic and a project manager for clinical systems at Syntex (Roche Group). Sabatini also founded Athena Consulting, where she worked with a number of life science companies, including Genentech, Applera, Iconix, and Align Technology.


GenoLogics Life Sciences Software has appointed Don Listwin its board of directors. Listwin most recently served as the president and CEO of Openwave Systems, a software provider for the communications industry. He also founded Canary Foundation, a non-profit organization dedicated to the early detection of cancer, in 2004. Listwin served as executive vice president of Cisco Systems for a decade before leaving the company in 2000.


Robert Tuttle has joined molecular diagnostic developer HistoRx as director of bioinformatics. Tuttle was previously group leader and bioinformatics systems manager at CuraGen. Prior to that, he held senior positions at TurboGenomics (now TurboWorx), and Gerber Scientific. Other recent new hires at HistoRx include Donna Marino, vice president of diagnostics, who most recently served as a principal at Genomic Healthcare Strategies; and Lorah Perlee, vice president of technical operations, who joins the firm from Protedyne, where she served as director of scientific applications.

Filed under

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.